Milestone Scientific, Inc. (MLSS) financial statements (2021 and earlier)
Company profile
| Business Address |
220 SOUTH ORANGE AVENUE LIVINGSTON, NJ 07039 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 2 | 2 | 2 | 3 | 1 | 0 | 1 | ||
| Cash and cash equivalents | 2 | 2 | 2 | 3 | 1 | 0 | 1 | ||
| Receivables | 2 | 1 | 2 | 2 | 2 | 2 | 5 | ||
| Inventory, net of allowances, customer advances and progress billings | 2 | 2 | 1 | 2 | 2 | 2 | 2 | ||
| Inventory | 2 | 2 | 1 | 2 | 2 | 2 | 2 | ||
| Deferred costs | 0 | 0 | 1 | 2 | |||||
| Advances on inventory purchases | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Other undisclosed current assets | 1 | 1 | 0 | 1 | 0 | 0 | 0 | ||
| Total current assets: | 6 | 6 | 6 | 7 | 6 | 7 | 11 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 0 | ✕ | ✕ | ✕ | |||||
| Property, plant and equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Intangible assets, net (including goodwill) | 0 | 0 | 0 | 0 | 0 | 0 | 2 | ||
| Intangible assets, net (excluding goodwill) | 0 | 0 | 0 | 0 | 0 | 0 | 2 | ||
| Other noncurrent assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Total noncurrent assets: | 0 | 0 | 0 | 1 | 1 | 1 | 2 | ||
| TOTAL ASSETS: | 7 | 6 | 7 | 8 | 6 | 8 | 13 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 2 | 1 | 3 | 3 | 3 | 3 | 3 | ||
| Accounts payable | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Accrued liabilities | 1 | 1 | 1 | 2 | 1 | 2 | 2 | ||
| Deferred revenue | 0 | ✕ | ✕ | ✕ | |||||
| Debt | 0 | 0 | 0 | 0 | |||||
| Due to related parties | 1 | 2 | 1 | 1 | 2 | 1 | 1 | ||
| Contract with customer, liability | ✕ | ✕ | ✕ | ✕ | 0 | ||||
| Other undisclosed current liabilities | 1 | 5 | 2 | 1 | 0 | 2 | 3 | ||
| Total current liabilities: | 5 | 8 | 6 | 5 | 5 | 7 | 8 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 0 | ||||||||
| Operating lease, liability | 0 | ✕ | ✕ | ✕ | |||||
| Total noncurrent liabilities: | 0 | ||||||||
| Total liabilities: | 5 | 8 | 6 | 5 | 5 | 7 | 8 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent | 2 | (1) | 1 | 3 | 2 | 1 | 5 | ||
| Preferred stock | 0 | 0 | 0 | 0 | |||||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Treasury stock, value | (1) | (1) | (1) | (1) | (1) | (1) | (1) | ||
| Additional paid in capital | 96 | 90 | 90 | 90 | 88 | 88 | 88 | ||
| Accumulated deficit | (94) | (91) | (88) | (87) | (86) | (86) | (82) | ||
| Stockholders' equity attributable to noncontrolling interest | (0) | (0) | (0) | (0) | (0) | 0 | 0 | ||
| Total stockholders' equity: | 2 | (1) | 1 | 3 | 2 | 1 | 5 | ||
| TOTAL LIABILITIES AND EQUITY: | 7 | 6 | 7 | 8 | 6 | 8 | 13 | ||
Income statement (P&L) ($ in millions)
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 2 | 2 | 2 | 2 | 4 | 2 | 2 | |
| Cost of revenue (Cost of Goods and Services Sold) | (1) | (1) | (1) | (1) | (2) | (2) | (1) | |
| Gross profit: | 2 | 1 | 2 | 1 | 2 | (0) | 1 | |
| Operating expenses | (3) | (2) | (3) | (2) | (2) | (4) | (3) | |
| Operating loss: | (1) | (1) | (1) | (1) | (0) | (5) | (1) | |
| Nonoperating income (expense) | (2) | (2) | 0 | 0 | (0) | (0) | 0 | |
| Investment income, nonoperating | (2) | (2) | 0 | 0 | 0 | 0 | 0 | |
| Other nonoperating expense | (0) | (0) | (0) | (0) | (0) | (0) | (0) | |
| Other undisclosed income from continuing operations before equity method investments, income taxes | 0 | 0 | 0 | 0 | ||||
| Loss from continuing operations before equity method investments, income taxes: | (3) | (3) | (1) | (1) | (0) | (5) | (1) | |
| Income (loss) from equity method investments | 0 | 0 | (0) | 0 | ||||
| Other undisclosed income from continuing operations before income taxes | 0 | |||||||
| Income (loss) from continuing operations before income taxes: | (3) | (3) | (1) | (1) | 0 | (5) | (1) | |
| Income tax expense (benefit) | 0 | (0) | (0) | (0) | (0) | (0) | (0) | |
| Income (loss) before gain (loss) on sale of properties: | (3) | (3) | (1) | (1) | 0 | (5) | (1) | |
| Other undisclosed net income (loss) | 0 | (0) | 0 | |||||
| Net income (loss): | (3) | (3) | (1) | (1) | 0 | (4) | (1) | |
| Net income attributable to noncontrolling interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Other undisclosed net loss attributable to parent | (0) | |||||||
| Net income (loss) available to common stockholders, diluted: | (3) | (3) | (1) | (1) | 0 | (4) | (1) | |
Comprehensive Income ($ in millions)
| 12/31/2019 Q4 | 9/30/2019 Q3 | 6/30/2019 Q2 | 3/31/2019 Q1 | 12/31/2018 Q4 | 9/30/2018 Q3 | 6/30/2018 Q2 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (3) | (3) | (1) | (1) | 0 | (4) | (1) | |
| Comprehensive income (loss): | (3) | (3) | (1) | (1) | 0 | (4) | (1) | |
| Comprehensive income, net of tax, attributable to noncontrolling interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Comprehensive income (loss), net of tax, attributable to parent: | (3) | (3) | (1) | (1) | 0 | (4) | (1) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.